Navigation Links
Ambiguity In Patent Laws May Defer New Drug Launches

Indian Government has refused to grant product patent for Glivec, the cancer drug from Novartis AG, the Swiss pharma giant. As a result Novartis may not be able to conduct// their drug research here in India. Singapore and China are the countries where Novartis conducts its research now.

While talking on this issue, Paul Herrling, who heads Corporate Research division of Novartis reveals that this decision by the Indian government could hamper the launch of their patented products. But this in any way will not affect the distribution of Glivec here. According to him, Novartis through its foundation has been distributing Glivec to needy patients to the tune of 1270 crore in India.

Trade analysts opine that if such drugs are not available freely in the market and are being prescribed by the physicians and supplied by a few pharmacies, it would prove to be very expensive to the patients.

Herrling feels that the primary objective of any drug company should be to improve health care services. They should focus their research on this area. Product patent alone is not sufficient but data individuality is more important.
JYT
'"/>




Page: 1

Related medicine news :

1. Botched Abortions Trigger Concern Over Legal Ambiguity In Britain
2. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
3. HIV Patients Opposes Patenting Of AIDS Drug
4. Provigil Patent Extension Accorded To Cephalon
5. AIDS Sufferers Protest against Proposed Patent for Tenofovir
6. POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals
7. Venus Remedies Files 5th International Patent Application
8. US Court Rules Against Lupin in Ramipril Patent Case
9. Patent for Seminal RNAi innovation Cleared in Australia
10. Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs
11. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... ... 2017 , ... Planet Fitness, one of the largest and fastest growing franchisors ... a flagship location in Covington, LA at 401 N. U.S. Highway 190, in January ... Office Depot in the Holiday Square shopping center. Its location allows it to serve ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017   Divoti USA will engrave and ... standard of the latest FDA requirements, which stipulates new criteria regarding ... in need of Medical ID jewelry such as Medical ID Bracelets, ... engraved in terms of the new FDA requirements . ... Divoti offers this dark mark fiber ...
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
Breaking Medicine Technology: